Nov 12 2009, 7:30 AM EST
News source: Business Wire
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that after the market closed on Tuesday, investors of CEL-SCI Corporation (NYSE AMEX:CVM) learned that the company had filed an "amended" Form S-3 with the SEC. The forms appears to be part of a $30 million bump to a previously filed "shelf offering" that had just been filed with the SEC a couple of weeks ago, on October 30th.
In that original filing, the company had disclosed that they were looking to raise only $10 million. The total now is $40 million. Was there a miscalculation? Did something unforeseen develop at the recent vaccine conference in D.C.?
These types of filings, while not usually publicized, give informed investors significant information regarding the securities offered, and are basically designed to help alert investors ahead of any sudden moves.
Still, one is left to wonder. Is this a "tell?" Especially given the timing of the SEC filing.
Speculation fuels the market and particularly stocks with as many pending news items at CEL-SCI has on it's calendar.
Some investors see this as a very bullish sign while critics pounce on CEl-SCI's possible motives and cry "Dilution!"
The complete report is available now at BioMedReports.Com:
Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/fda-calendar/fda-calendar.html
About BioMedReports.Com
BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid, compensated or in any way incentivized to report news and developments about publicly traded companies.
For more biomedical sector and investment news go to http://BioMedReports.com
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All